The PHS significantly predicted progression from MCI to AD over 120 months follow-up (p = 1.07e-5), and PHS was a significantly stronger predictor of progression than APOE ε genotype (p = 0.0152, for model comparison of APOE vs. APOE +PHS). This evidence concerns the gene APOE and Alzheimer disease.